Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

Parkinson’s is a progressive neurological condition driven by the loss of dopamine-producing neurons, which causes tremors, ...

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

Creighton University’s Health Sciences Campus in Phoenix and Midwestern University in Glendale collaborated on a study that ...

An international research collaboration led by Rutgers University-New Brunswick scientists that examined microscopic blobs of protein found in human cells has discovered that some morph from an almost ...

A new pill, tavapadon, has shown potential in easing Parkinson’s symptoms while limiting side effects. In patients taking at ...

Reacting to the findings of the trials, which have been published in the journal Nature, Claire Bale, associate director of ...

The phase I clinical trials showed stem cell transplants for Parkinson’s disease appear to be safe and might restore dopamine-producing brain cells.

Figure 1 | Stem-cell therapy for Parkinson’s disease. Parkinson’s disease is caused by a progressive loss of dopamine-releasing (dopaminergic) neurons in the brain.

April is Parkinson’s Disease Awareness Month. Studies show that every six minutes, someone will be diagnosed with Parkinson’s Disease. “It’s incredibly important ...

With a cure for Parkinson's disease remaining elusive, the sport of ping pong is providing relief for people living with pain ...